German antitrust authorities have reportedly approved of Fenwal Holdings’ takeover by Fresenius SE. Fenwal Holdings specializes in blood collection equipment, and Fresenius is a German healthcare company. According to sources, the deal was inked at $1.1 billion and was agreed-upon last July.
Featured News
States Prepare Antitrust Challenge to Paramount-Warner Bros. Deal
Jun 7, 2026 by
CPI
Epic Urges Supreme Court to Reject Apple’s Appeal in Ongoing App Store Dispute
Jun 7, 2026 by
CPI
Italy’s Banco BPM Seeks Merger Talks With Monte dei Paschi as Rival Banks Weigh Options
Jun 7, 2026 by
CPI
Türkiye Opens Investigation Into Meta Over WhatsApp AI Integration
Jun 7, 2026 by
CPI
SpaceX Lands Multi-Year Google Cloud Deal
Jun 7, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – (Geo)Political Antitrust
May 28, 2026 by
CPI
Competition Policy in Turbulent Geopolitical Times
May 28, 2026 by
Christophe Carugati & Annabelle Gawer
The New Political Determinants of U.S. Antitrust Policy
May 28, 2026 by
Aziz Z. Huq
The Geopolitical Rewiring of Antitrust
May 28, 2026 by
Hayane C. Dahmen
Three Strikes Against Political Antitrust
May 28, 2026 by
Nolan McCarty & Sepehr Shahshahani